Supercritical fluid extraction provides an enhancement to the immune response for orally-delivered hepatitis B surface antigen

Vaccine

Volumn 32, Issue 11, 2014, Pages 1240-1246

  Hayden, Celine A ^a   Smith, Emily M ^a   Turner, Debra D ^b   Keener, Todd K ^a   Wong, Jeffrey C ^a   Walker, John H ^a   Tizard, Ian R ^b   Jimenez Flores, Rafael ^a   Howard, John A ^a  

^a CALIFORNIA POLYTECHNIC STATE UNIVERSITY   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

Author keywords

Bioencapsulation; HBsAg; Hepatitis B; Immunogenicity; Mucosal; Oral vaccine; Plant vaccine; Supercritical fluid extraction

Indexed keywords

BIOENCAPSULATION; HBSAG; HEPATITIS B; IMMUNOGENICITY; MUCOSAL; ORAL VACCINE; PLANT VACCINE; SUPERCRITICAL FLUID EXTRACTION;

ADMINISTRATION, ORAL; ANIMALS; CHROMATOGRAPHY, SUPERCRITICAL FLUID; HEPATITIS ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; IMMUNITY, MUCOSAL; IMMUNOGLOBULIN A; IMMUNOGLOBULIN A, SECRETORY; IMMUNOGLOBULIN G; MICE; MICE, INBRED BALB C; PLANTS, GENETICALLY MODIFIED; VACCINES, SUBUNIT; VACCINES, SYNTHETIC; ZEA MAYS;

EID: 84893981474     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.01.037     Document Type: Article

References (40)

1. Ott J.J., Stevens G.A., Groeger J., Wiersma S.T. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine 2012, 30(12):2212-2219.
2. Hayden CA. An oral vaccine for hepatitis B: challenges, setbacks, and breakthroughs. In: Howard JA, Hood EE, editors. Commercial plant-produced recombinant protein products: case studies. Springer, accepted.
3. Ahishali E., Boztas G., Akyuz F., Ibrisim D., Poturoglu S., Pinarbasi B., Ozdil S., Mungan Z. Response to hepatitis B vaccination in patients with celiac disease. Digestive Diseases and Sciences 2008, 53(8):2156-2159.
4. Landrum M.L., Hullsiek K.H., O'Connell R.J., Chun H.M., Ganesan A., Okulicz J.F., Lalani T., Weintrob A.C., Crum-Cianflone N.F., Agan B.K. Hepatitis B vaccine antibody response and the risk of clinical aids or death. PLoS One 2012, 7(3):e33488.
5. Laurence J.C., Hepatitis A. B immunizations of individuals infected with human immunodeficiency virus. American Journal of Medicine 2005, 118(10):75-83.
6. Leonardi S., Spina M., Spicuzza L., Rotolo N., La Rosa M. Hepatitis B vaccination failure in celiac disease: is there a need to reassess current immunization strategies?. Vaccine 2009, 27(43):6030-6033.
7. Roome A.J., Walsh S.J., Cartter M.L., Hadler J.L. Hepatitis B vaccine responsiveness in Connecticut public safety personnel. Journal of the American Medical Association 1993, 270(24):2931-2934.
8. Tohme R.A., Awosika-Olumo D., Nielsen C., Khuwaja S., Scott J., Xing J., Drobeniuc J., Hu D.J., Turner C., Wafeeg T. Evaluation of hepatitis B vaccine immunogenicity among older adults during an outbreak response in assisted living facilities. Vaccine 2011, 29:9316-9320.
9. Vida Pérez L., Gómez Camacho F., García Sánchez V., Iglesias Flores E.M., Castillo Molina L., Cerezo Ruiz A., Casáis Juanena L., De Dios Vega J.F. Eficacia de la vacuna contra el virus de la hepatitis B en pacientes con enfermedad inflamatoria intestinal. Medicina Clínica 2009, 132(9):331-335.
10. Williams R.E., Sena A.C., Moorman A.C., Moore Z.S., Sharapov U.M., Drobenuic J., Hu D.J., Wood H.W., Xing J., Spradling P.R. Hepatitis B vaccination of susceptible elderly residents of long term care facilities during a hepatitis B outbreak. Vaccine 2012, 30(21):3147-3150.
11. Zitt E., Sprenger-Mähr H., Knoll F., Neyer U., Lhotta K. Vitamin D deficiency is associated with poor response to active hepatitis B immunisation in patients with chronic kidney disease. Vaccine 2011, 30:931-935.
12. Nisihara R., De Bem R., Negreiros P., Utiyama S., Oliveira N., Amarante H. Low hepatitis B vaccine response in children with Down syndrome from Brazil. Child: Care, Health and Development 2013, 10.1111/cch.12099.
13. Vermeiren A., Hoebe C.J., Dukers-Muijrers N.H. High non-responsiveness of males and the elderly to standard hepatitis B vaccination among a large cohort of healthy employees. Journal of Clinical Virology 2013, 58(1):262-264.
14. Lu P.-j., Byrd K.K., Murphy T.V., Weinbaum C. Hepatitis B vaccination coverage among high-risk adults 18-49 years. US, 2009. Vaccine 2011, 29(40):7049-7057.
15. Lum P.J., Ochoa K.C., Hahn J.A., Shafer K.P., Evans J.L., Moss A.R. Hepatitis B virus immunization among young injection drug users in San Francisco, Calif: the UFO study. American Journal of Public Health 2003, 93(6):919-923.
16. Nyamathi A.M., Marlow E., Branson C., Marfisee M., Nandy K. Hepatitis A/B vaccine completion among homeless adults with history of incarceration. Journal of Forensic Nursing 2012, 13-22.
17. Linkins R.W., Chonwattana W., Holtz T.H., Wasinrapee P., Chaikummao S., Varangrat A., Tongtoyai J., Mock P.A., Curlin M.E., Sirivongrangson P. Hepatitis A and hepatitis B infection prevalence and associated risk factors in men who have sex with men, Bangkok, 2006-2008. Journal of Medical Virology 2013, 85(9):1499-1505.
18. MacKellar D.A., Valleroy L.A., Secura G.M., McFarland W., Shehan D., Ford W., LaLota M., Celentano D.D., Koblin B.A., Torian L.V. Two decades after vaccine license: hepatitis B immunization and infection among young men who have sex with men. American Journal of Public Health 2001, 91(6):965-971.
19. Simard E.P., Miller J.T., George P.A., Wasley A., Alter M.J., Bell B.P., Finelli L. Hepatitis B vaccination coverage levels among healthcare workers in the United States, 2002-2003. Infection Control and Hospital Epidemiology 2007, 28(7):783-790.
20. Hayden C.A., Egelkrout E.M., Moscoso A.M., Enrique C., Keener T.K., Jimenez-Flores R., Wong J.C., Howard J.A. Production of highly concentrated: heat-stable hepatitis B surface antigen in maize. Plant Biotechnology Journal 2012, 10(8):979-984.
21. Thanavala Y., Mahoney M., Pal S., Scott A., Richter L., Natarajan N., Goodwin P., Arntzen C.J., Mason H.S. Immunogenicity in humans of an edible vaccine for hepatitis B. Proceedings of the National Academy of Sciences of the United States of America 2005, 102(9):3378-3382.
22. Hayden C.A., Streatfield S.J., Lamphear B.J., Fake G.M., Keener T.K., Walker J.H., Clements J.D., Turner D.D., Tizard I.R., Howard J.A. Bioencapsulation of the hepatitis B surface antigen and its use as an effective oral immunogen. Vaccine 2012, 30(19):2937-2942.
23. Fischer R., Stoger E., Schillberg S., Christou P., Twyman R.M. Plant-based production of biopharmaceuticals. Current Opinion in Plant Biology 2004, 7(2):152-158.
24. Lamphear B.J., Streatfield S.J., Jilka J.M., Brooks C.A., Barker D.K., Turner D.D., Delaney D.E., Garcia M., Wiggins B., Woodard S.L., Hood E.E., Tizard I.R., Lawhorn B., Howard J.A. Delivery of subunit vaccines in maize seed. J Control Release 2002, 85(1-3):169-180.
25. Pignitter M.V., Somoza Critical evaluation of methods for the measurement of oxidative rancidity in vegetable oils. Journal of Food and Drug Analysis 2012, 20(4):772-777.
26. 2 in green chemical synthesis and processing. Journal of Supercritical Fluids 2004, 28(2):121-191.
27. Typical Composition of Yellow Dent Corn. Available from: http://www.docstoc.com/docs/27164545/Typical-Composition-of-Yellow-Dent-Corn (accessed 20.09.2013).
28. Eskin N., Przybylski R. Antioxidants and shelf life of foods. Food shelf life Stability: chemical, biochemical, and microbiological changes 2010, 175-210. CRC Press.
29. Gent J.F. Apparatus for degermination and decortication of Indian corn. US Patent No. 735664 1903, US Patent Office.
30. Beall Degerminator Co. Available from http://www.bealldeg.com (accessed 26.09.2013).
31. Satake Group. Available from: http://www.satake-group.com/about/scope.html (accessed 26.09.2013).
32. 2-assisted aerosolization. Journal of Pharmaceutical Sciences 2001, 90(6):785-797.
33. Gießauf A., Gamse T. A simple process for increasing the specific activity of porcine pancreatic lipase by supercritical carbon dioxide treatment. Journal of Molecular Catalysis B: Enzymatic 2000, 9(1):57-64.
34. Friedrich J.P., List G.R. Characterization of soybean oil extracted by supercritical carbon dioxide and hexane. Journal of Agricultural and Food Chemistry 1982, 30(1):192-193.
35. List G., Friedrich J. Oxidative stability of seed oils extracted with supercritical carbon dioxide 1. Journal of the American Oil Chemists Society 1989, 66(1):98-101.
36. Rónyai E., Simandi B., Tömösközi S., Deák A., Vigh L., Weinbrenner Z. Supercritical fluid extraction of corn germ with carbon dioxide-ethyl alcohol mixture. Journal of Supercritical Fluids 1998, 14(1):75-81.
37. Astaire J., Ward R., German J., Jimenez-Flores R. Concentration of polar MFGM lipids from buttermilk by microfiltration and supercritical fluid extraction. Journal of Dairy Science 2003, 86(7):2297-2307.
38. Froning G., Wehling R., Cuppett S., Pierce M., Niemann L., Siekman D. Extraction of cholesterol and other lipids from dried egg yolk using supercritical carbon dioxide. Journal of Food Science 1990, 55(1):95-98.
39. Gavilanes F., Gonzalez-Ros J.M., Peterson D.L. Structure of hepatitis B surface antigen. Characterization of the lipid components and their association with the viral proteins. Journal of Biological Chemistry 1982, 257(13):7770-7777.
40. Weder J.K. Effect of supercritical carbon dioxide on proteins. Zeitschrift für Lebensmittel-Untersuchung und Forschung 1980, 171(2):95-100.